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Cardiac complications are a leading cause of
morbidity and death in vascular surgery patients.1-3
Data from several historical studies4-7 and one recent
prospective trial8 suggest that patients who undergo
vascular surgery can benefit from the identification
and correction of problems with cardiac perfor-
mance (hemodynamic optimization, or “tune up”)
in the preoperative period, which leads to reduced
perioperative morbidity and mortality rates. Manip-
ulation of cardiac performance is guided by data
derived from pulmonary artery catheters (PACs),
which remain in place for intraoperative and postop-
erative monitoring. In a small randomized study,
preoperative tune up and PAC monitoring in
patients who underwent infrainguinal bypass opera-
tions were associated with fewer adverse intraopera-
tive events, reduced cardiac morbidity, and an
improved early graft patency rate.8 However, there is
no clear benefit of monitoring patients who under-
go aortic surgery with a PAC.9,10 In fact, the ratio-
nale of monitoring any critically ill patient with a
PAC has recently been challenged by a multiinstitu-
tional, prospective cohort study.11 Results from ret-
rospective studies in aortic surgery patients have
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suggested that preoperative hemodynamic optimiza-
tion reduces perioperative cardiac, renal, and other
complications.4,7
Because these patients tend to have fewer med-
ical problems and may have fewer cardiac complica-
tions than patients who undergo infrainguinal
bypass operations,12,13 we hypothesized that preop-
erative hemodynamic optimization and periopera-
tive monitoring with PACs would not reduce the
morbidity and mortality rates of aortic surgery. The
purposes of this study were to determine whether
the morbidity and mortality rates of aortic surgery
are reduced by preoperative hemodynamic optimiza-
tion and perioperative monitoring with a PAC and
to determine the relative number of patients who
undergo aortic surgery with identifiable cardiac per-
formance abnormalities.
METHODS
This study was approved by the Institutional
Review Board of the Dallas Department of Veterans
Affairs Medical Center. All patients who underwent
elective abdominal aortic reconstruction between
March 1994 and March 1997 were considered for
enrollment. Exclusion criteria included myocardial
infarction within 3 months, coronary revasculariza-
tion (CABG) within 6 weeks, severe aortic or mitral
valve disease, unstable angina or recent change in
anginal symptoms, and clinically overt congestive
heart failure (CHF). These exclusion criteria repre-
sent clinical situations that are associated with a high
risk of perioperative cardiac morbidity and death,8,14
which would preclude withholding PAC monitoring
in these circumstances.15 We also excluded patients
with advanced, chronic renal insufficiency (serum
creatinine level 3.0 mg/dl or greater) in whom care-
ful monitoring of intravascular volume status with a
PAC was considered essential to prevent renal fail-
ure.5,16,17 Finally, we excluded infrequent patients
who were undergoing redo aortic operations and
those in whom additional procedures such as
femoropopliteal or renal artery bypass grafting were
performed.
Cardiac evaluation. After thorough history
and physical examination, all patients underwent
objective assessment of coronary perfusion with
adenosine thallium-201 scintigraphy (Fig. 1).
Adenosine was infused at 140 m g/kg/min for 6
minutes. With 1 minute left in the infusion, 2 to 3
mCi of thallium-201 was injected. Tomographic
images were acquired using a three-headed gamma
camera (Toshiba 9300 three-head gamma counter
with a low-energy, high-resolution parallel collima-
tor, Toshiba American Medical Systems, Tustin,
Calif.) immediately and at 4 hours after injection. A
scan result was considered normal if there was nor-
mal radioisotope uptake that was uniform in all
segments of the myocardium in early and delayed
images. A fixed defect was defined as a regional
area of decreased thallium uptake that was present
on both early and delayed images. A reversible
defect was defined as a region of decreased thalli-
um uptake on the initial images that was no longer
present on the delayed images. Patients who had
normal scan results or fixed defects were offered
enrollment into the study without further cardiac
evaluation. Patients who had reversible defects
were referred to the cardiology service. Depending
on the clinical situation, these patients either
underwent cardiac catheterization or were treated
medically. The decision to proceed with aortic
surgery, to perform preliminary CABG, or to can-
cel the aortic surgery was made in conjunction with
the consulting cardiologist.
Study groups. Patients were entered consecu-
tively in the order of their scheduled operations.
After informed consent was obtained, patients were
randomized into two groups by means of a sealed
envelope opened on the afternoon before surgery.
Subjects in the first group (PAC) were taken to the
intensive care unit (ICU) at least 14 hours before
surgery. After placement of the PAC, cardiovascular
physiologic parameters were measured, including
mean arterial pressure, central venous pressure, pul-
monary capillary wedge pressure (PCWP), and car-
diac output. Systemic vascular resistance (SR), pul-
monary vascular resistance, and cardiac index (CI)
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Fig. 1.  Cardiac evaluation scheme.
were calculated from these measurements. Intravas-
cular volume and cardiac performance were “opti-
mized” to the preestablished parameters used by
Berlauk and associates8 using an algorithm of inter-
vention outlined in Fig. 2. Fluid challenges for PAC
patients with PCWP less than 15 mm Hg consisted
of 9 ml/kg Ringer’s lactate solution rapidly instilled
through the central venous pressure port. Addition-
al fluid boluses were given until the PCWP was
greater than 12 mm Hg or the subject received 3000
ml of fluid. Subjects with an SR greater than 1100
dyne/sec × cm5 received a continuous infusion of
nitroglycerin (0.3 to 4 m g/kg/min), or nitroprus-
side (0.3 to 8 m g/kg/min) if nitroglycerin was inef-
fective. Inotropic effect was achieved with intra-
venous dopamine (2 to 9 m g/kg/min). PAC
patients were considered to be optimized if the fol-
lowing hemodynamic goals were reached, all of
which have been previously associated with im-
proved outcome8: (1) 8 mm Hg ≤ PCWP < 15 mm
Hg; (2) CI ‡ 2.8 L/min/m2; (3) SR ≤ 1100
dyne/sec× cm5. Once these end points were reached,
PAC patients received intravenous maintenance flu-
ids at 1 to 2 ml/kg/hr. Any patient who could not
meet end point criteria had surgery postponed for
reevaluation by the cardiology service. If later
attempts at optimization were unsuccessful, the
patient was excluded from further participation.
Control patients were not transferred to the
ICU, did not undergo placement of a PAC, and did
not undergo hemodynamic optimization. These
patients received isotonic fluids via peripheral intra-
venous line at 1 to 2 ml/kg/hr and were transferred
directly to the operating room on the morning of
surgery.
Perioperative management. Patients in both
groups underwent a standardized anesthesia rou-
tine. Radial arterial lines were placed for continuous
blood pressure monitoring. Indwelling epidural
catheters were placed for postoperative pain control.
Patients in the control group underwent placement
of percutaneous sheaths (Percutaneous Sheaths with
Side Port/Hemostasis Valve Catheters, Arrow Inter-
national, Reading, Pa.) for access to the central
venous system in case conditions were met that indi-
cated placement of a PAC during the operation. As
a provision for managing adverse intraoperative
complications, control patients would undergo
placement of a PAC during operation if one of the
following occurred: sustained, refractory hypoten-
sion (systolic blood pressure less than 85 mm Hg);
persistent echocardiographic (ECG) changes; urine
output less than 0.5 ml/kg in 1 hour; and persistent
PaO2 less than 80 torr on FIO2 1.0. Premedication
consisted of fentanyl (2 m g/kg) and lidocaine (1.5
mg/kg). Neuromuscular blockade with 0.1 mg/kg
vancuronium was given to assist with intubation.
Patients were induced with etomidate (0.2 to 0.3
mg/kg) and were maintained with isoflurane and
nitrous oxide in oxygen. After operation, a continu-
ous infusion of 0.125% bupivacaine with 5 m g/ml
fentanyl was administered through the epidural
catheter for pain relief until the patient was dis-
charged from the ICU. In the postoperative period,
daily 12-lead ECG and cardiac enzymes were
obtained on all subjects for 5 days.
Measured outcome. Subjects in both groups
were monitored for the following adverse intraoper-
ative events, which have been associated with
increased perioperative morbidity8: (1) sustained
(>5 min) mean arterial pressure ≤70% of baseline,
preinduction value; (2) heart rate ‡ 30% over base-
line value; (3) new arrhythmias that required treat-
ment; (4) new ECG changes (1 mm ST segment
depression, T-wave inversion); (5) oliguria (urine
output <0.5 ml/kg in 1 hour); (6) increased peak
airway pressure >40 mm Hg; (7) acute bron-
chospasm; and (8) hypoxemia (PaO2 <80 torr on
FIO2 1.0).
Subjects were monitored for the following
adverse postoperative events: (1) acute myocardial
infarction (ECG or enzyme criteria); (2) arrhythmias
that required treatment; (3) CHF (pulmonary
edema); (4) acute renal failure; (5) noncardiogenic
pulmonary insufficiency; (6) cerebrovascular acci-
dent; (7) graft thrombosis; and (8) death.
Duration of ventilation, duration of stay in the
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 2 Valentine et al. 205
Fig. 2.  Regimen for preoperative tune up in patients ran-
domized to receive PACs.
ICU, and length of hospital stay in the postoperative
period were tabulated for all subjects. Catheter-relat-
ed complications were also recorded. Study end
points included discharge from the hospital and
death from any cause. Placement of a PAC in a con-
trol patient for any reason was also considered a
study end point.
Statistics. Continuous data are expressed as
mean ± SEM. Statistical comparisons between cate-
gorical parameters were performed with c 2 analysis.
Comparisons between groups of unpaired data were
made using Student’s t test. Differences were con-
sidered significant if the p value was less than 0.05.
Examination of multivariate risk effects was made
using stepwise logistic regression. Significance levels
for entry into the model and retention were set at a
p value less than 0.1.
RESULTS
Patient enrollment. One hundred thirty-three
patients underwent elective aortic revascularization
at our institution during the study period, and 126
of these met the inclusion criteria. All were men. No
women underwent aortic revascularization at the
Dallas Department of Veterans Affairs Medical Cen-
ter during the study period. Three patients with
serum creatinine levels of 3.0 mg/dl or greater were
excluded, as was one patient who underwent redo
aortic surgery and three patients who required addi-
tional procedures at the time of aortic revasculariza-
tion. No patients with cardiac exclusion criteria
underwent elective aortic operations during the
study period.
Fifty-eight of the 126 eligible patients (46%) had
a normal result of adenosine thallium-201 scintigra-
phy, 20 (16%) had fixed defects, and 48 (38%) had
reversible defects. After cardiology consultation, 18
of the patients with reversible defects (14%) were
referred for coronary catheterization. The remaining
108 patients who met eligibility criteria were enrolled
into the study without further cardiac evaluation.
Among the 30 patients with reversible defects who
did not undergo cardiac catheterization, 16 were ran-
domized to the PAC group and 14 were randomized
to the control group (p = no significant difference).
Of the 18 patients who underwent coronary
catheterization, two died during the catheterization
procedure. Six of the 16 patients who survived
catheterization were referred for preliminary CABG
on the basis of compelling coronary anatomy and
severe angina pectoris. The other 10 patients were
enrolled into the study without CABG. Three of the
six patients who underwent preliminary CABG died
during the perioperative period. Of the three who
survived preliminary CABG, one required amputa-
tion without aortic revascularization, and two
became eligible for inclusion in the study 6 weeks
after CABG. In all, a total of 120 patients were
enrolled into the present study.
Sixty patients were randomized into the PAC
group, and 60 were randomized to the control
group. Thirty-one PAC patients (52%) underwent
repair of infrarenal aortic aneurysms (AAA), and 29
(48%) underwent aortic reconstruction for occlusive
disease. This was not significantly different from the
control group, in which 27 patients (45%) under-
went AAA repair and 33 (55%) underwent aortic
reconstruction. Patient demographics and athero-
sclerotic risk factors are shown for both groups in
Table I. Cardiac data for both groups are shown in
Table II. There were no statistically significant dif-
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Table I.  Patient demographics and atherosclerotic
risk factors
PAC patients Control subjects
Age (yr) 64 ± 1 63 ± 1.2
AAA* 31 (52%) 29 (48%)
Race
Black 4 (7%) 4 (7%)
Hispanic — 2 (3%)
White 56 (93%) 54 (90%)
Smoking 49 (82%) 49 (82%)
Hypertension 36 (60%) 37 (62%)
Diabetes 11 (18%) 7 (12%)
Hyperlipidemia† 25 (42%) 23 (38%)
Preexisting renal 12 (20%) 8 (13%)
insufficiency‡
Differences are not statistically different between groups.
*Patients who underwent aortic surgery for aneurysmal disease;
the remainder underwent aortic surgery for occlusive disease.
†Serum cholesterol >240 mg/dl or serum triglycerides >300
mg/dl.
‡Serum creatinine level >1.5 mg/dl.
Table II. Cardiac data
PAC patients Control subjects
Angina 11 (18%) 15 (25%)
History of CHF 5 (8%) 3 (5%)
Chronic arrhythmia 3 (5%) 8 (13%)
Prior MI 23 (38%) 15 (25%)
Prior CABG 16 (27%) 14 (23%)
ATS
Normal 27 (45%) 31 (52%)
Fixed defect 9 (15%) 11 (18%)
Reversible defect 24 (40%) 18 (30%)
Differences not statistically significant between groups.
MI, Myocardial infarction; ATS, adenosine thallium-201 scintig-
raphy.
ferences with respect to the results observed from
thallium scintigraphy in either group. Thirty-five
PAC patients (58%) had at least one of the cardiac
risk factors noted in Table II, which was not signifi-
cantly different compared with 32 control subjects
(53%). b -blockers were not administered routinely
during the preoperative period. Ten PAC patients
(17%) and 10 control subjects (17%) received b -
blocking agents on a chronic basis.
Perioperative results. All PAC patients met end
point criteria for hemodynamic optimization (Table
III). PAC patients received a mean initial fluid chal-
lenge of 1360 ± 110 ml, and no patient received
more than 3000 ml. After fluid challenge, 30 PAC
patients (50%) had persistent cardiac performance
abnormalities, which corrected with intravenous
nitrate administration in 28 patients (nitroglycerin,
20; nitroprusside, 8) and with intravenous nitro-
prusside and dopamine in two patients. Including
maintenance fluids, PAC patients received a mean of
2620 ± 150 ml during the preoperative period, com-
pared with 1010 ± 50 ml for the control subjects (p
< 0.001).
Seven of the PAC patients (12%) and four con-
trol subjects (7%) underwent placement of tube
grafts for AAA repair; the remainder underwent
placement of bifurcated grafts (p = no significant dif-
ference). There were no differences between the
groups in mean operative time, estimated blood loss,
or intraoperative fluid administration.
Eleven PAC patients (18%) had intraoperative
complications, compared with three control subjects
(5%; p = 0.02). These included prolonged hypoten-
sion (four PAC patients, three control subjects), new
arrhythmias (two PAC patients, no control subjects),
sustained tachycardia (two PAC patients, no control
subjects), sustained bradycardia (two PAC patients,
no control subjects), and bronchospasm (one PAC
patient, no control subjects). Differences in the
number of specific complications were not signifi-
cant between the groups. Four PAC patients and
one control patient had sustained hypotension at the
time of declamping. The four PAC patients had been
maintained at optimal hemodynamics on the basis of
intraoperative data derived from the PAC. In all five
patients, hypotension was readily corrected with
additional fluids. Soon after induction of anesthesia,
profound shock developed in the other two control
patients with sustained hypotension. Both patients
met criteria for placement of a PAC because
hypotension was not quickly corrected with fluids
and inotropic agents. PAC data suggested that the
cause of hypotension was related to volume deficits
in both instances, although both had received more
than 1000 ml of fluid during the preoperative peri-
od. Neither had reversible defects on adenosine thal-
lium scintigraphy. The operations were canceled,
and the patients were transported to the ICU for
observation. Neither patient had cardiac complica-
tions, and both underwent uncomplicated aortic
reconstructions within 1 week. Placement of a PAC
is considered a study end point in both cases. These
patients are included in the present complication
analysis on the basis of intention to treat, but neither
is included in the outcome analysis below. None of
the other control patients met criteria for placement
of PACs.
Postoperative complications. Maintenance of
optimal cardiac performance on the basis of data
derived from PACs was continued in the PAC
patients during the postoperative period. None of
the control subjects required placement of a PAC
after operation. Fifteen PAC patients (25%) experi-
enced adverse outcomes, which was not significant-
ly different than 10 control subjects (17%; Table
III). Cardiac events occurred in nine PAC patients
(15%) and five control subjects (8%; p = NS). Car-
diac events included myocardial infarction (four
PAC patients, two control subjects), new arrhyth-
mias (four PAC patients, three control subjects), and
CHF (one PAC patient, no control subjects).
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Table III. Outcome
PAC patients Control subjects p
Intravenous 
fluids (ml)
Preoperative 2620 ± 150 1010 ± 50 0.001
Intraoperative 5700 ± 290 6030 ± 280 NS
Postoperative 5100 ± 270 4060 ± 190 0.002
Operative time 241 ± 9 255 ± 10 NS
(min)
Estimated blood 1200 ± 170 1100 ± 130 NS
loss (ml)
Duration of 35 ± 19 6 ± 1 NS
ventilation (hr)
Intraoperative 11 (18%) 3 (5%) 0.02
complications
Postoperative 15 (25%) 10 (17%) NS
complications
Cardiac 9 (15%) 5 (7%) NS
Pulmonary 7 (12%) 5 (9%) NS
Renal 4 (7%) 1 (2%) NS
Stroke — —
Graft thrombosis — —
Duration of 8 ± 1 7 ± 1 NS
postoperative
ICU stay (d)
Duration of 13 ± 2 13 ± 2 NS
postoperative 
hospital stay (d)
Death 3 (5%) 1 (2%) NS
Although PAC patients tended to have a higher inci-
dence of individual cardiac events, differences
between the groups did not achieve statistical signif-
icance. Myocardial infarctions were associated with
left ventricular dysfunction and malignant arrhyth-
mias in three PAC patients; myocardial infarctions
were uncomplicated in the fourth PAC patient and
in the two control patients. No patient died of a car-
diac complication during this study.
Pulmonary complications occurred in seven PAC
patients (12%) and five control subjects (8%; p =
NS). These included pneumonia (four PAC patients,
three control subjects) and noncardiogenic pul-
monary insufficiency (three PAC patients, two con-
trol subjects). After surgery, the mean duration of
mechanical ventilation was 35 ± 19 hours for the
PAC patients and 6 ± 1 hours for the control sub-
jects (p = NS). Six PAC patients (10%) and two con-
trol subjects (3%) required mechanical ventilation
for more than 24 hours (p = NS).
Four PAC patients (7%) and one control patient
(2%) had acute renal insufficiency. Two of the PAC
patients required temporary hemodialysis but recov-
ered renal function within 6 months. The other two
PAC patients and the one control patient did not
require hemodialysis and had spontaneous recovery
of renal function within 1 month.
PAC patients received significantly more fluid in
the first 24 hours after operation than control sub-
jects (Table III). Duration of ICU stay and duration
of postoperative hospital stay were not different
between the two groups (Table III). All grafts were
patent at the time of discharge. There were no cases
of early graft occlusion.
Three PAC patients and one control patient died
during the perioperative period (p = NS), for an
overall mortality rate of 3.3%. All four deaths were
associated with sepsis (three of pneumonia, one of
cholecystitis) and multisystem organ failure. As
noted above, there were no deaths that were attrib-
utable to cardiac complications in this series.
Catheter complications. Eight PAC patients
(13%) experienced catheter-related complications;
there were no catheter-related complications among
the control subjects (p = 0.004). Five PAC patients
(8%) had transient arrhythmias during placement of
the PAC, none of which required treatment. One
patient (2%) had a pneumothorax after placement of
a PAC. Two PAC patients (3%) had catheter sepsis.
The latter diagnosis was made on the basis of posi-
tive blood cultures and resolution of symptoms after
catheter removal. Both PACs had been in place for 5
days at the time of sepsis. Both patients survived,
and no sequelae have occurred in either patient dur-
ing late follow-up.
Secondary analysis. To evaluate variables that
were associated with an adverse cardiac outcome, we
performed univariate comparisons. Of the variables
listed in Tables I and II, only CHF (p = 0.02; odds
ratio, 3.75; confidence interval, 1.3 to 11) and
reperfusion defects on adenosine thallium-201
scintigraphy (p = 0.01; odds ratio, 3.4; confidence
interval, 1.2 to 9.4) were significant. Among the 40
patients with reperfusion defects who were not
referred for preliminary CABG, cardiac events
occurred in two of the 10 patients (20%) who under-
went preoperative cardiac catheterization, which was
not significantly different compared with seven of
the 30 patients (23%) who were not referred for car-
diac catheterization. Both CHF (p = 0.09) and
reperfusion defects on adenosine thallium-201
scintigraphy (p = 0.04) retained significance in the
multivariate model. The sensitivity of adenosine
thallium scintigraphy was 0.64, and the specificity
was 0.69. The positive predictive value of a
reversible defect was 0.22, and the negative predic-
tive value was 0.94.
DISCUSSION
Whittemore and associates4 popularized the
practice of PAC-guided hemodynamic tune up and
maintenance of optimal cardiac performance in
patients who are undergoing AAA repair. Their ini-
tial report in 1980 suggested that this technique was
responsible for the low perioperative mortality rate
and improved late survival rate in their patients, but
the study was retrospective and was based on histor-
ical control subjects. Our results demonstrated no
benefit from hemodynamic tune up and periopera-
tive monitoring with PACs, even though 50% of
PAC patients had identified cardiac performance
abnormalities that required vasodilators, inotropic
agents, or both for correction. On the contrary,
there were higher rates of adverse intraoperative
events and catheter-related complications in the
PAC group. The PAC patients received significantly
more fluid in the preoperative period, which may
explain why prolonged bradycardia or bron-
chospasm occurred in three PAC patients and none
of the control subjects. Excess fluid administration
may have been particularly detrimental in PAC
patients with CHF and reversible defects, but the
small number of affected patients prevents meaning-
ful analysis. Tachyarrhythmias may have occurred
from catheter irritation. Ectopy is the most frequent
complication reported in patients with PACs,18 and
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it is certainly possible that the two PAC patients in
this study who had prolonged intraoperative tachy-
cardia had misdiagnosed atrial arrhythmias. On the
other hand, sustained tachycardia may have been
associated with volume deficits. As such, the results
demonstrate that tune up does not always prevent
intraoperative volume depletion, and PAC monitor-
ing may not detect volume deficits before they
become clinically apparent. There was no difference
in the incidence of sustained hypotension between
the groups, which suggests that hemodynamic tune
up and intraoperative monitoring with PACs does
not prevent this complication. The incidence of
catheter-related complications from PACs in this
series parallels the findings of previous reports.18,19
Only two control subjects required placement of
a PAC. Both cases were associated with significant
adverse events that resulted in cancellation of
surgery. It is conceivable that preoperative place-
ment of PACs would have identified the volume
deficits in both patients and that the original opera-
tions would not have been canceled. However, even
considering the gravity of the outcome in these two
cases, the use of a PAC was not associated with a sig-
nificant benefit in the study group as a whole. These
results suggest that the vast majority of patients can
safely undergo aortic surgery without placement of a
PAC. However, as a contingency for monitoring
adverse events, we continue to recommend place-
ment of central venous lines for PAC access should
this become necessary in individual cases. The pre-
sent results suggest that this is rare.
PAC patients tended to have more cardiac and
pulmonary complications, although the differences
did not achieve statistical significance. Secondary
analysis identified other variables as more significant
predictors of cardiac risk, and these corroborate the
findings of others.13,20 Although reversible defects
on adenosine thallium-201 scintigraphy were signif-
icantly associated with adverse cardiac outcome, we
would point out that the test was associated with a
low positive predictive value and a high negative pre-
dictive value. Thus adenosine-thallium scintigraphy
appears to be most valuable in determining which
patients do not require further preoperative cardiac
evaluation. It is a poor predictor of which patients
will have cardiac events. These results are in keeping
with those published previously.21
Although there were a large number of patients
in both groups who had objective evidence of
advanced coronary artery disease, only 14% of eligi-
ble patients underwent coronary catheterization,
and only six (5%) ultimately underwent preliminary
CABG. These results were in large part dictated by
our cardiology consultants, who have generally
restricted invasive coronary screening to highly
selected patients with severe symptoms. The fact
that there were no cardiac deaths in this series after
aortic reconstruction supports this approach. The
perioperative myocardial infarction rate of 5% is sim-
ilar to reported rates from other institutions2,22 and
well within results (including CABG mortality rate)
reported from institutions with higher rates of pre-
liminary CABG before vascular surgery.23 It should
be stressed that half of our patients who were
referred for preliminary CABG died before vascular
surgery. We believe that this underscores the high
medical risk of the patients who were referred for
CABG; others have shown that patients with periph-
eral vascular disease have a higher operative mortali-
ty rate than expected after CABG.24 One other
patient was excluded from the present study because
he underwent amputation before recovering from
the CABG procedure. This demonstrates the ur-
gency of vascular repair in some patients who cannot
tolerate having the peripheral vascular procedure
postponed for CABG.
Despite the fact that this was a randomized,
prospective trial from a single institution, limitations
did exist. First, it is possible that some intraoperative
or postoperative complications were not detected in
our patients. However, the intensity of observation
for adverse events necessitated by the present study
design makes this unlikely. At any rate, because there
was an equal risk of missed complications in both
groups, it is doubtful that the results would have
been altered significantly.
Although the differences in the number of
adverse perioperative events did not achieve statisti-
cal significance, the risk of a type II statistical error
must be acknowledged. The likelihood of statistical
significance with the effect size of an 8% difference
in the rate of cardiac complications observed in the
present study was only 0.29. We speculate that the
higher number of cardiac and renal complications in
the PAC group represent an important trend and
that a significant difference might be observed
among a larger study population. We also speculate
that the longer duration of ventilation in the PAC
patients represents an important trend that might
have reached statistical significance with a larger
study group. On the basis of the present data, we
calculate that approximately 480 patients would be
required to demonstrate a statistical difference in
cardiac events (80% power).
Another potential limitation is that the nature of
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our referral population restricted this study to men.
Our findings therefore do not apply to women. Pre-
vious reports have demonstrated that women who
undergo vascular surgery have operative outcomes
similar to those of men.25,26 Furthermore, the
prevalence of coronary disease in women is less than
that in men.23 By extrapolation, we speculate that
preoperative optimization and PAC monitoring is
not beneficial in women who undergo aortic
surgery.
Finally, it should be emphasized that our con-
clusions regarding the use of PACs in aortic
surgery are limited to the protocol used in this
study. The present study design was based on the
protocol used by Berlauk and associates,8 who
demonstrated improved outcome in patients who
underwent infrainguinal bypass and placement of
PACs. The protocol ensured a stepwise correction
of cardiac function abnormalities and, we believe,
offered the best circumstances for rejecting the null
hypothesis.
CONCLUSION
The present results suggest that the majority of
patients who undergo aortic surgery will not ben-
efit from hemodynamic optimization and periop-
erative monitoring with PACs using this protocol,
even though as many as 50% have potentially iden-
tifiable cardiac function abnormalities. It has been
suggested by others that these patients might not
require admission to the hospital for overnight
hydration before surgery.27,28 Current financial
constraints in many hospitals have led to a policy
of same-day admission with rapid hydration in the
hour before surgery. Although the safety of this
approach has not been evaluated, the severe
hypotension that developed in two control
patients on anesthesia induction stresses the
importance of ensuring adequate volume repletion
in patients who undergo vascular surgery.
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DISCUSSION
Dr. Harry L. Bush Jr. (New York, N.Y.).Twenty
years ago we reported to this Society that judicious
modulation of intravascular volume and myocardial
stress during aortic aneurysm repair is an essential com-
ponent of surgical management and can best be moni-
tored by Starling’s myocardial performance curves.
However, since that time, the selection, preparation,
and anesthetic treatment of aneurysmal patients has
changed dramatically and now includes preoperative
control of chronic hypertension, preoperative cardiac
assessment, anesthetic techniques to minimize tachycar-
dias and afterload stress, proper management of
intravascular volume, minimal use of banked blood, and
preservation of core temperature.
As you have heard, Dr. Valentine and his coworkers
have tackled one aspect of this strategy and reported a sin-
gle-institution randomized, prospective evaluation of the
efficacy of pulmonary artery catheterization in patients
who undergo elective aortic reconstruction. It is an excel-
lent study, as we have come to expect from these individ-
uals. The manuscript tracks 100% of the patients with
intent-to-treat and clearly describes their outcomes. Their
analysis demonstrates that in good-risk patients without
clinically significant wall motion abnormalities or coronary
insufficiency, no benefit could be ascribed to the use of
perioperative monitoring with pulmonary artery catheters.
However, I would like to raise several questions.
In any clinical study, statistical significance can be
achieved with a small number of patients only if the test-
ed group is at risk for a bad outcome. The authors have
carefully defined cardiac risk before operation and
excluded certain patients who were at high risk. These
excluded patients were at such high risk that 27% died
during the evaluation and therapy for their coronary
artery disease. By preselecting patients who are at lower
risk for adverse cardiac complications, any beneficial role
for pulmonary artery catheters would expectedly be
more difficult to define.
Second, I have been under the impression clinically that
aortic occlusive patients tolerate aortic clamping and
unclamping more smoothly than do patients with
aneurysms. Because only 50% of your patients had aneurys-
mal disease, could this further dilute the patients who were
at risk for hemodynamic complications? In your analysis,
were there any differences in the hemodynamic profiles or
adverse outcomes between the two populations of aortic dis-
ease, specifically the occlusive versus the aneurysmal patients?
Third, pooled data can sometimes hide important infor-
mation about intraoperative complications. Are there any
specific factors that might explain the declamping hypoten-
sion noticed in the seven patients, four of whom were in the
monitored group?
Lastly, tachyarrhythmias were a common feature in the
pulmonary artery catheter group. Was there any difference
or intensity of b -blockade or dopamine infusion between
your two groups?
In spite of these questions, Dr. Valentine, you and
your group have performed a great service to us in
designing and effectively completing this excellent
study, which does show a lack of benefit for routine
perioperative monitoring with pulmonary artery
catheters in carefully selected patients with aneurysmal
and occlusive aortic disease. Although I do not wish to
detract from these results and their potential impact on
developing practice guidelines for aneurysmal patients, I
would introduce a note of caution. I am reminded of
the truism that you only find what you specifically look
for in complicated patients. In caring for any individual
patient who is undergoing aortic reconstruction, igno-
rance is definitely not bliss.
Dr. R. James Valentine. Thank you very much, Dr.
Bush. We agree wholeheartedly that improvements in
preoperative management and anesthetic technique dur-
ing the past 20 years have led to a dramatic decrease in
operative morbidity and mortality rates, eclipsing the
benefit of preoperative tune up that you demonstrated
so clearly in 1977.
Regarding the issue of our study exclusion criteria, I
would stress that the vast majority of patients under
consideration for aortic surgery were enrolled into this
study. Of the original 126 patients who met inclusion
criteria, only six were not enrolled. Five of these patients
died during coronary catheterization or coronary artery
bypass grafting, and one underwent amputation before
he could recover from coronary artery bypass grafting.
There was a high prevalence of coronary artery disease
and other medical problems in the 120 enrolled
patients, and adenosine thallium scintigraphy suggested
that 35% were at high risk for cardiac complications. I
do not think that we preselected patients at lower risk.
If fact, we only excluded the very sickest patients, such
as those with recent myocardial infarctions or overt con-
gestive heart failure, in whom we did not feel it was eth-
ical to withhold pulmonary artery catheters.
Your second question related to whether there was a
difference in the incidence of declamping hypotension
in patients with aneurysms compared with those who
had occlusive disease. The answer is no. The very small
number of episodes of declamping hypotension were
equally divided between patients with aneurysms and
those with occlusive disease. We were unable to define
any specific factors that might explain why declamping
hypotension occurred, other than to note that the
hypotension was corrected in all five instances with
additional fluid administration. Two other control
patients had severe hypotension at the time of anesthe-
sia induction. We believe that this underscores the
importance of adequate volume repletion during the
preoperative period.
Your last question was regarding tachyarrhythmias.
Only two patients with pulmonary artery catheters
received intravenous dopamine during the preoperative
period. Intraoperative dopamine infusion was equally
divided between the groups. Regarding the use of b -
blockers, none of the study patients received routine b -
blockade in the preoperative period. The small number
of patients who received intraoperative b -blockers was
equally divided between the groups.
Dr. Paula M. Muto (Lynn, Mass.). I enjoyed your
study very much. We all are curious, because a lot of us
are not allowed to admit our patients 24 hours before
admission for preoperative tune up. I have two ques-
tions. First of all, in your preoperative tune up, in terms
of the end points, did you use oxygen delivery as one of
those end points or just simply cardiac output and car-
diac index?
My second question is whether you measured hemo-
globin before operation, immediately before surgery.
Was there a difference in hemoglobin level between the
control population and those patients who were hydrat-
ed aggressively the night before surgery? Because that
may have an impact on their morbidity rate during the
surgery if they started off more anemic.
Dr. Valentine. Thank you for your questions. We
did not measure oxygen delivery as an end point for pre-
operative tune up, nor did we compare preoperative
hemoglobin levels between the two groups.
Dr. Kenneth Grant (Charlottetown, Prince Edward
Island, Canada). In your optimization of patients with
pulmonary artery catheters before surgery, you pushed
them up to a cardiac index of 2.8. I wonder whether
perhaps in doing that you made some frail patients even
more frail. If you had used some other index, like stroke
work, perhaps you wouldn’t have pushed them so hard.
And perhaps you accomplished 2.8 by tachycardia, off
the top of their Starling curves and more susceptible to
complications.
Dr. Valentine. We used Starling curves to determine
whether patients were being pushed beyond their limits
with fluid loading. Although many patients required
intravenous nitrates, dopamine, or both to correct car-
diac performance abnormalities, none was pushed onto
the negative slope area of the curve. The two patients
who required dopamine had slight elevations in their
baseline heart rates, but certainly less than 10% over the
mean heart rate before the dopamine was started.
Dr. Paul J. Gagne (Chesapeake, Va.). Dr. Valen-
tine, I enjoyed your paper. Did any of your patients
undergo intraoperative transesophageal echocardiogra-
phy? And if so, could this have affected the lack of ben-
efit in your pulmonary artery catheter group?
Dr. Valentine. We did not use transesophageal
echocardiography in aortic patients for the duration of
this study.
Dr. Thomas F. Lindsay (Toronto, Ontario, Cana-
da). In Canada it is becoming the standard that most
aortic surgery patients are having an epidural placed
before operation. There is variable usage by the anes-
thetist during the operation. We believe that this has
made a significant impact, especially in the postoperative
period. Our anesthetists have argued that they need a
pulmonary artery wedge catheter during the procedure
if they are giving epidural local anesthetic during the
operation because it allows them to distinguish between
hypotension based on decreased peripheral vascular
resistance versus decreased cardiac output. Did any of
your patients have intraoperative use of the epidural and
do you think this will affect the results of this study?
Dr. Valentine. Our patients had a standardized
anesthesia routine, which was agreed on by all of the
anesthesiologists at the Dallas VA Hospital before insti-
tution of the study. Patients all had epidural catheters
placed before operation, and they did not receive any
dosing until the postoperative period, that is to say, until
the operation was completed and they were on their way
back to the intensive care unit.
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